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The Clinical Picture
A skin lesion after cardiac catheterization
A 64-year-old man with diabetes and hy-pertension presented with a 2-day history 
of sudden onset of acute pain and cyanosis on 
the sole of his right foot 4 days after undergo-
ing cardiac catheterization and coronary an-
giography.
 The physical examination revealed macu-
lar, violaceous, connecting rings in a net-like 
pattern that blanched with pressure and dis-
appeared when the foot was elevated, a pre-
sentation compatible with livedo reticularis 
(Figure 1). Laboratory testing (complete blood 
cell count, biochemistry panel, coagulation 
test, and C-reactive protein test) was notable 
only for eosinophilia. 
 A few days later, the patient returned with 
abdominal pain, diarrhea, and acute renal in-
jury with urinary eosinophils (7% of the white 
blood cells in the urine) and proteinuria. 
Q: Which is the most likely diagnosis?
 □ Infective endocarditis
 □ Pernio (chilblain)
 □ Cholesterol crystal embolism
 □ Cutaneous small-vessel vasculitis
A: Cholesterol crystal embolism is the correct 
diagnosis.
 Infective endocarditis is an infection of 
the endocardium, but systemic signs may be 
present, including cutaneous lesions such as 
Osler nodes (painful papules on the tips of the 
fingers and toes) and Janeway lesions (painless 
macules on the palms and soles). Histologic 
staining of skin biopsy specimens often shows 
vasculitis, occasionally with a positive Gram 
stain. Severe renal injury is not common, and 
the timing of the acute illness and skin lesion 
fits better with an acute embolic phenomenon. 
 Pernio is a form of cold injury, localized in 
peripheral parts of the body and occurring after 
exposure to cold temperatures in damp condi-
tions. It usually manifests bilaterally as pain-
ful erythematous or purple lesions on the acral 
areas of the hands and feet, nose, ears, and, 
rarely, the thighs and buttocks. Pernio most 
commonly affects women between 20 and 40 
years of age. It can be idiopathic or associated 
with a systemic disease such as systemic lupus 
erythematosus or Sjögren syndrome. 
 Cutaneous small-vessel vasculitis is a het-
erogeneous group of disorders with inflamma-
tion and damage of the blood vessels; it may be 
limited to the skin or it may involve multiple 
systems. Palpable or nonpalpable purpura and 
ulceration are common clinical findings, and 
histologic study shows an inflammatory infil-
trate of vessel walls, fibrinoid necrosis, throm-
bosis, and extravasation of red blood cells. 
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Figure 1. Macular violaceous connecting rings in a 
net-like pattern compatible with livedo reticularis 
on the foot.
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 While this patient’s problems are not con-
sistent with small-vessel vasculitis, the single 
skin lesion, the timing after the catheteriza-
tion, and the urinary eosinophils are best ex-
plained by cholesterol embolization.
 ■ Cholesterol Crystal embolism
Cholesterol crystal embolism is commonly iatro-
genic, a complication of mechanical damage 
to the arterial walls from vascular surgery or 
invasive percutaneous procedures. Material 
dislodged from atheromatous arterial plaques 
can occlude the small vessels of the feet, pro-
ducing this syndrome.
 The onset of the clinical disease is often 
delayed for days to weeks after an angio-
graphic procedure.1 Spontaneous hemorrhage, 
disruption of plaque, or drug therapy with an 
anticoagulant or a fibrinolytic can precipi-
tate embolization of cholesterol crystals. The 
source of the emboli is atheromatous plaque in 
major blood vessels, particularly the abdomi-
nal aorta.
many organs and systems can be affected
These emboli can affect many organs and sys-
tems: eg, the kidneys (causing hypertension 
and acute renal failure), the muscles (causing 
myalgias), gastrointestinal organs (causing 
bleeding, abdominal pain, and bowel infarc-
tion), the lungs (causing acute respiratory 
distress syndrome), the eyes (causing Hollen-
horst plaques in retinal arteries), and the cen-
tral nervous system (causing stroke, confusion, 
and delirium). Cardiac or central nervous sys-
tem involvement is associated with a high risk 
of death. 
 After angiography, clinical manifestations 
of cholesterol embolization have been report-
ed in 0.06% to 1.4% of patients,2,3 although 
the finding of cholesterol emboli is more com-
mon in autopsy studies.4 
recognizing skin signs is the key
Cutaneous abnormalities are usually the ear-
liest and often the only clinical manifesta-
tion of this syndrome. Findings on the lower 
limbs include blue toes, cutaneous nodules, 
and livedo reticularis, affecting the feet and 
legs and sometimes extending upward to the 
trunk. Other findings include digital infarcts, 
ulceration, gangrene, purpura, cyanosis, and 
splinter hemorrhages in the nail bed.
 In our patient, microscopic study of skin 
biopsy specimens showed needle-shaped clefts 
within the lumen of blood vessels—ie, dis-
solved cholesterol crystals obstructing small 
arteries (Figure 2).
 Biopsy studies of skin lesions are posi-
tive in a high percentage of cases, showing 
dissolved cholesterol crystals within the lu-
men of blood vessels, especially in the small 
to large arteries and arterioles of the deep 
dermis or subcutaneous fat. Deep biopsies 
and carefully examination are necessary, as 
emboli tend to be patchily distributed. Early 
recognition of cutaneous clinical findings is 
essential to establish the proper diagnosis 
and treatment.
 The diagnostic triad of this disease in-
cludes blue toe syndrome, acute or subacute 
renal failure, and a temporal relation with an 
inciting event (particularly angiography). But 
despite these diagnostic criteria,2 the diagnosis 
is often based on a combination of signs and 
symptoms specific to end-organ damage and a 
systemic inflammatory response.3 
 Histologic confirmation is considered es-
sential to the diagnosis of cholesterol crystal 
embolism, and as the skin is the most acces-
sible site, skin biopsy provides the best sample 
for histologic diagnosis.5 
 Postprocedural embolism of a blood clot, 
vasculitis, and infective endocarditis are the 
most important differential diagnoses.6,7
Figure 2. Skin biopsy showed needle-shaped clefts 
within the lumen of blood vessels, ie, dissolved cho-
lesterol crystals obstructing small arteries.
The diagnostic 
triad: blue toe 
syndrome, 
acute or  
subacute renal 
failure, and a 
recent inciting 
event such as 
angiography
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treatment is supportive, preventive
Treatment is mainly supportive with hemo-
dynamic monitoring, nutritional and meta-
bolic support, mechanical ventilation, and 
dialysis if necessary. The underlying athero-
sclerotic disease should be treated aggressive-
ly. Prevention of another episode involves 
modification of traditional risk factors such 
as serum cholesterol, diabetes, hypertension, 
and smoking. Additional vascular surgery 
procedures should be avoided, as they can in-
duce new episodes. ■
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